Evidence map›Paper›PMID 39627609›Full record

ArticleCellular & molecular immunology2025

Dynamic O-GlcNAcylation governs long-range chromatin interactions in V(D)J recombination during early B-cell development.

Bong Chan Jeon, Yu-Ji Kim, Ae Kyung Park, Mi-Ran Song, Ki Myeong Na, Juwon Lee, Dasom An, Yeseul Park, Heeyoun Hwang, Tae-Don Kim and 2 more

Abstract read
In one paragraph

Article in Cellular & molecular immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bong Chan Jeon *Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.
Yu-Ji Kim *Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.
Ae Kyung Park *Department of Pharmacy, School of Pharmacy and Institute of New Drug Development, Jeonbuk National University, Jeonju, Republic of Korea.
Mi-Ran SongInfectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.
Ki Myeong NaInfectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.ORCID 0009-0008-6457-451X
Juwon LeeDepartment of Pharmacy, School of Pharmacy and Institute of New Drug Development, Jeonbuk National University, Jeonju, Republic of Korea.
Dasom AnDigital OMICs Research Center, Korea Basic Science Institute, Cheongju, Republic of Korea.
Yeseul ParkDigital OMICs Research Center, Korea Basic Science Institute, Cheongju, Republic of Korea.
Heeyoun HwangDigital OMICs Research Center, Korea Basic Science Institute, Cheongju, Republic of Korea.
Tae-Don KimDepartment of Functional Genomics, KRIBB School of Bioscience, Korea University of Science and Technology (UST), Daejeon, Republic of Korea.ORCID 0000-0002-5910-4264
Junghyun LimDepartment of Pharmacy, School of Pharmacy and Institute of New Drug Development, Jeonbuk National University, Jeonju, Republic of Korea. jl1206@jbnu.ac.kr.ORCID 0000-0002-5292-7487
Sung-Kyun ParkInfectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea. skpark@kribb.re.kr.ORCID 0000-0003-2838-4520

Funding

Korea Research Institute of Bioscience and Biotechnology (KRIBB) KGM9942421National Research Council of Science and Technology (National Research Council of Science & Technology) NTC2642311National Research Council of Science and Technology (National Research Council of Science & Technology) ZYM9382312National Research Foundation of Korea (NRF) 2020R1I1A3073845National Research Foundation of Korea (NRF) 2021R1A2C1012477National Research Foundation of Korea (NRF) 2021R1I1A2057945National Research Foundation of Korea (NRF) 2022M3E5F1016693
6 · The paper itself

Abstract

V(D)J recombination secures the production of functional immunoglobulin (Ig) genes and antibody diversity during the early stages of B-cell development through long-distance interactions mediated by cis-regulatory elements and trans-acting factors. O-GlcNAcylation is a dynamic and reversible posttranslational modification of nuclear and cytoplasmic proteins that regulates various protein functions, including DNA-binding affinity and protein-protein interactions. However, the effects of O-GlcNAcylation on proteins involved in V(D)J recombination remain largely unknown. To elucidate this relationship, we downregulated O-GlcNAcylation in a mouse model by administering an O-GlcNAc inhibitor or restricting the consumption of a regular diet. Interestingly, the inhibition of O-GlcNAcylation in mice severely impaired Ig heavy-chain (IgH) gene rearrangement. We identified several factors crucial for V(D)J recombination, including YY1, CTCF, SMC1, and SMC3, as direct targets of O-GlcNAc modification. Importantly, O-GlcNAcylation regulates the physical interaction between SMC1 and SMC3 and the DNA-binding patterns of YY1 at the IgH gene locus. Moreover, O-GlcNAc inhibition downregulated DDX5 protein expression, affecting the functional association of CTCF with its DNA-binding sites at the IgH locus. Our results showed that locus contraction and long-range interactions throughout the IgH locus are disrupted in a manner dependent on the cellular O-GlcNAc level. In this study, we established that V(D)J recombination relies on the O-GlcNAc status of stage-specific proteins during early B-cell development and identified O-GlcNAc-dependent mechanisms as new regulatory components for the development of a diverse antibody repertoire.

Indexed as

B-LymphocytesChromatinV(D)J RecombinationYY1 Transcription FactorAcetylglucosamineAnimalsCCCTC-Binding FactorCell Cycle ProteinsCell DifferentiationChromosomal Proteins, Non-HistoneImmunoglobulin Heavy ChainsMiceMice, Inbred C57BLProtein BindingProtein Processing, Post-TranslationalRepressor ProteinsAcetylglucosamineCCCTC-Binding FactorCell Cycle ProteinsChromatinChromosomal Proteins, Non-HistoneCtcf protein, mouseImmunoglobulin Heavy ChainsRepressor ProteinsYy1 protein, mouseYY1 Transcription FactorCohesin complexDDX5O-GlcNAcylationV(D)J recombinationYY1 and CTCF DNA binding

Identifiers

PMID39627609
PMCPMC11686140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.